Europe small molecule drug delivery market is expected to reach US$ 13,381.71 million by 2027 from US$ 6,835.97 million in 2019. The market is anticipated to grow with a CAGR of 9.0% from 2020 to 2027.
Small molecules drugs are used in targeted drug delivery in which small molecules pass through the cell membrane and acts on the specific cellular organelle or protein. The small molecules drugs are able to enter cells easily because of its low molecular weight. These molecules are better than monoclonal antibodies and other large molecule drugs due to their size, easy convertibility to oral form and cost affectivity. The discovery of novel small molecule entities that are capable of specific interactions represents a significant challenge in the early stages of drug discovery.
Germany Small Molecule Drug Delivery Market Revenue and Forecast to 2027 (US$ Million)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Growing Developments and Start-Ups in Small Molecules Drug Delivery Market
Small molecules offer innovative medications for the four significant indications, such as oncology, diabetes, autoimmune, and respiratory diseases. For instance, combination with large molecules as antibody-drug conjugates (ADC), allowing more precise treatment of cancer. Additionally, small molecule protein kinase inhibitors are becoming increasingly important in cancer therapy. This has led to increasing product approvals of small molecule drugs and growing number of start-up companies, which are the prime factors for the growth of the small molecule drug discovery market.
Hungray based ChemPass founded in 2016, generate molecular structures based on user-defined criteria. It design novel small organic molecules and scaffolds. Additionally, Molomics headquarter in Barcelona, Catalonia, Spain uses artificial intelligence (AI) in drug discovery to design structurally new small molecules for validated biological targets. This allows researchers to collaborate with each other (using what they call "Human Collective Intelligence") and AI to jointly develop safer and more effective therapeutics. Owing to above mentioned factors, the market for small molecule drug delivery is likely to grow in the forecasted period.
Therapeutic Type- Based Market Insights
Based on therapeutic type, the small molecule drug delivery market is further segmented into oncology, central nervous system, cardiovascular, respiratory, orthopedics, immunology, rare diseases, and other therapeutic areas. The oncology segment held the largest share of the market in 2019, however, rare diseases is anticipated to register the highest CAGR in the market during the forecast period.
Europe Small Molecule Drug Delivery Market, by Therapeutic Type– 2019 and 2027Process/Phase -Based Market Insights
Based on process/phase, the small molecule drug delivery market is segmented into target discovery, target validation, lead generation and refinement, and preclinical development. The lead generation and refinement segment held the largest share of the market in 2019. Moreover, target discovery is estimated to register the highest CAGR during the forecast period.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Europe Small Molecule Drug Delivery Market: Strategic Insights
Market Size Value in | US$ 6,835.97 Million in 2019 |
Market Size Value by | US$ 13,381.71 Million by 2027 |
Growth rate | CAGR of 9.0% from 2020-2027 |
Forecast Period | 2020-2027 |
Base Year | 2020 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to AnalystProduct launches and approvals are commonly adopted strategies by companies to expand their footprint worldwide and meet the growing demand. The players operating in the small molecule drug delivery market adopt the expansion, collaboration, and product launch strategies to enlarge customer base across the world. These strategies allow the players to maintain their brand name globally. For instance, in May 2018, Cloud Pharmaceuticals, Inc., an AI-driven drug design and development company, entered into drug discovery collaboration with GlaxoSmithKline (GSK), wherein Cloud will bedesigning novel small-molecule agents for GSK specified targets through its proprietary AI-driven process to design the molecules.
By Therapeutic Area
- Oncology
- Central Nervous System
- Cardiovascular
- Respiratory
- Orthopedics
- Immunology
- Rare Diseases
- Other Therapeutic Areas
By Process/Phase
- Target Discovery
- Target Validation
- Lead Generation and Refinement
- Preclinical Development
By Country
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
Company Profiles
- Merck KGaA
- GlaxoSmithKline plc
- AstraZeneca
- Boehringer Ingelheim International GmbH
- Allergan Plc
- Pfizer Inc.
- Bristol-Myers Squibb Company
- Johnson & Johnson Services, Inc.
- Teva Pharmaceutical Industries Ltd
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Therapeutic Area, Process/Phase, and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
UK, Germany, France, Italy, Russia
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Small Molecule Drug Discovery Market – By Therapeutic Area
1.3.2 Europe Small Molecule Drug Discovery Market – By Process/Phase
1.3.3 Europe Small Molecule Drug Delivery Market– By Region
2. Small Molecule Drug Delivery Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Small Molecule Drug Delivery – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Europe
4.3 Expert Opinion
5. Europe Small Molecule Drug Delivery Market – Industry Dynamics
5.1 Key Drivers
5.1.1 Growing Demand for R&D from Contract Organizations
5.1.2 Growing Developments and Start-Ups in Small Molecules Drug Delivery Market
5.2 Market Restraints
5.2.1 High Cost of Drug Development
5.3 Market Opportunities
5.3.1 Growing Small Molecule Drug Delivery Product Approvals and Collaborations
5.4 Future Trends
5.4.1 Growing Adoption of Artificial Intelligence in Drug Discovery
5.5 Impact analysis
6. Small Molecule Drug Delivery Market – Regional Analysis
6.1 Europe Small Molecule Drug Delivery Market Revenue Forecast And Analysis
6.2 Market Positioning of Key Players
7. Small Molecule Drug Discovery Market– By Therapeutic Area
7.1 Overview
7.2 Small Molecule Drug Discovery Market Share, by Therapeutic Area, 2019 and 2027 (%)
7.3 Oncology
7.3.1 Overview
7.3.2 Oncology: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)
7.4 Central Nervous System
7.4.1 Overview
7.4.2 Central Nervous System: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)
7.5 Cardiovascular
7.5.1 Overview
7.5.2 Cardiovascular: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)
7.6 Respiratory
7.6.1 Overview
7.6.2 Respiratory: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)
7.7 Orthopedics
7.7.1 Overview
7.7.2 Orthopedics: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)
7.8 Immunology
7.8.1 Overview
7.8.2 Immunology: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)
7.9 Rare Diseases
7.9.1 Overview
7.9.2 Rare Diseases: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)
7.10 Other Therapeutic Areas
7.10.1 Overview
7.10.2 Other Therapeutic Areas: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)
8. Small Molecule Drug Discovery Market – By Process/Phase
8.1 Overview
8.2 Small Molecule Drug Discovery Market, by Process/Phase, 2019 and 2027 (%)
8.3 Target Discovery
8.3.1 Overview
8.3.2 Target Discovery: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Target Validation
8.4.1 Overview
8.4.2 Target Validation: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Lead Generation and Refinement
8.5.1 Overview
8.5.2 Lead Generation and Refinement: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (US$ Million)
8.6 Preclinical Development
8.6.1 Overview
8.6.2 Preclinical Development: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (US$ Million)
9. Small Molecule Drug Discovery Market – Geographic Analysis
9.1 Europe: Small Molecule Drug Discovery Market
9.1.1 Overview
9.1.2 Europe: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (USD Millions)
9.1.3 Europe: Small Molecule Drug Discovery Market, by Therapeutic Area, 2018–2027 (USD Millions)
9.1.4 Europe: Small Molecule Drug Discovery Market, by Process/ Phase, 2018-2027 (USD Millions)
9.1.5 Europe: Small Molecule Drug Discovery Market, by Country, 2019 & 2027 (%)
9.1.5.1 Germany: Small Molecule Drug Discovery Market
9.1.5.1.1 Germany: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Millions)
9.1.5.1.2 Germany: Small Molecule Drug Discovery Market, by Therapeutic Area, 2018-2027 (USD Millions)
9.1.5.1.3 Germany: Small Molecule Drug Discovery Market, by Process/ Phase, 2018-2027 (USD Millions)
9.1.5.2 United Kingdom: Small Molecule Drug Discovery Market
9.1.5.2.1 United Kingdom: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Millions)
9.1.5.2.2 United Kingdom: Small Molecule Drug Discovery Market, by Therapeutic Area, 2018-2027 (USD Millions)
9.1.5.2.3 United Kingdom: Small Molecule Drug Discovery Market, by Process/ Phase, 2018-2027 (USD Millions)
9.1.5.3 France: Small Molecule Drug Discovery Market
9.1.5.3.1 France: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Millions)
9.1.5.3.2 France: Small Molecule Drug Discovery Market, by Therapeutic Area, 2018-2027 (USD Millions)
9.1.5.3.3 France: Small Molecule Drug Discovery Market, by Process/ Phase, 2018-2027 (USD Millions)
9.1.5.4 Italy: Small Molecule Drug Discovery Market
9.1.5.4.1 Italy: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Millions)
9.1.5.4.2 Italy: Small Molecule Drug Discovery Market, by Therapeutic Area, 2018-2027 (USD Millions)
9.1.5.4.3 Italy: Small Molecule Drug Discovery Market, by Process/ Phase, 2018-2027 (USD Millions)
9.1.5.5 Spain: Small Molecule Drug Discovery Market
9.1.5.5.1 Spain: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Millions)
9.1.5.5.2 Spain: Small Molecule Drug Discovery Market, by Therapeutic Area, 2018-2027 (USD Millions)
9.1.5.5.3 Spain: Small Molecule Drug Discovery Market, by Process/ Phase, 2018-2027 (USD Millions)
10. Impact Of COVID-19 Pandemic On Europe Small Molecule Drug Delivery Market
10.1 Europe: Impact Assessment of COVID-19 Pandemic
11. Small Molecule Drug Discovery Market –Company Profiles
11.1 Merck KGaA
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 GlaxoSmithKline plc.
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 AstraZeneca
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Boehringer Ingelheim International GmbH
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Allergan Plc.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms
LIST OF TABLES
Table 1. Europe Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Millions)
Table 2. Europe Small Molecule Drug Discovery Market, by Process/ Phase – Revenue and Forecast to 2027 (USD Millions)
Table 3. Germany Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 ( USD Millions)
Table 4. Germany Small Molecule Drug Discovery Market, by Process/ Phase – Revenue and Forecast to 2027 (USD Millions)
Table 5. United Kingdom Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Millions)
Table 6. United Kingdom Small Molecule Drug Discovery Market, by Process/ Phase – Revenue and Forecast to 2027 (USD Millions)
Table 7. France Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Millions)
Table 8. France Small Molecule Drug Discovery Market, by Process/ Phase – Revenue and Forecast to 2027 (USD Millions)
Table 9. Italy Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Millions)
Table 10. Italy Small Molecule Drug Discovery Market, by Process/ Phase – Revenue and Forecast to 2027 (USD Millions)
Table 11. Spain Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Millions)
Table 12. Spain Small Molecule Drug Discovery Market, by Process/ Phase – Revenue and Forecast to 2027 (USD Millions)
Table 13. Glossary of Terms, Small Molecule Drug Discovery Market
LIST OF FIGURES
Figure 1. Small Molecule Drug Delivery Market Segmentation
Figure 2. Small Molecule Drug Delivery Segmentation – By Region
Figure 3. Europe Small Molecule Drug Delivery Market Overview
Figure 4. The Oncology Segment Held Largest Share and Rare Diseases Segment Expected To Grow With Highest Growth Rate
Figure 5. Germany Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Europe PEST Analysis
Figure 7. Small molecule drug discovery Market Impact Analysis of Driver and Restraints
Figure 8. Europe Small Molecule Drug Delivery Market – Revenue Forecast And Analysis – 2019- 2027
Figure 9. Market Positioning of Key Players In Europe Small Molecule Drug Discovery Market
Figure 10. Small Molecule Drug Discovery Market Share, by Therapeutic Area, 2019 and 2027 (%)
Figure 11. Oncology: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)
Figure 12. Central Nervous System: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)
Figure 13. Cardiovascular: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)
Figure 14. Respiratory: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)
Figure 15. Orthopedics: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)
Figure 16. Immunology: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)
Figure 17. Rare Diseases: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)
Figure 18. Other Therapeutic Areas: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)
Figure 19. Small Molecule Drug Discovery Market, by Process/Phase, 2019 and 2027 (%)
Figure 20. Target Discovery: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 21. Target Validation: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 22. Lead Generation and Refinement: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 23. Preclinical Development: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 24. Europe: Small Molecule Drug Discovery Market, by Key Country – Revenue (2019) (USD Millions)
Figure 25. EuropeSmall Molecule Drug Discovery Market Revenue and Forecast to 2027 (USD Millions)
Figure 26. Europe: Small Molecule Drug Discovery Market, by Country, 2019 & 2027 (%)
Figure 27. Germany Small Molecule Drug Discovery Market Revenue and Forecast to 2027 (USD Millions)
Figure 28. United KingdomSmall Molecule Drug Discovery Market Revenue and Forecast to 2027 (USD Millions)
Figure 29. FranceSmall Molecule Drug Discovery Market Revenue and Forecast to 2027 (USD Millions)
Figure 30. ItalySmall Molecule Drug Discovery Market Revenue and Forecast to 2027 (USD Millions)
Figure 31. SpainSmall Molecule Drug Discovery Market Revenue and Forecast to 2027 (USD Millions)
Figure 32. Impact of COVID-19 Pandemic In European Country Markets
- Merck KGaA
- GlaxoSmithKline plc
- AstraZeneca
- Boehringer Ingelheim International GmbH
- Allergan Plc
- Pfizer Inc.
- Bristol-Myers Squibb Company
- Johnson & Johnson Services, Inc.
- Teva Pharmaceutical Industries Ltd
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Europe Small Molecule Drug Delivery Market
Aug 2020
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2020
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Aug 2020
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Aug 2020
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2020
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2020
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Aug 2020
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Aug 2020
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)